| Claude Lyle, MD | |
|
4301 W Markham St # 783, Little Rock, AR 72205-7101 | |
| (501) 686-8000 | |
| Not Available |
| Full Name | Claude Lyle |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 4301 W Markham St # 783, Little Rock, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174610224 | NPI | - | NPPES |
| P00288788 | Other | AR | RAILROAD MEDICARE |
| 154473001 | Medicaid | AR | |
| P00247351 | Other | AR | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | E-3855 (Arkansas) | Primary |
| Entity Name | Baptist Medcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699868323 PECOS PAC ID: 5698667624 Enrollment ID: O20040325001348 |
News Archive
Mothers who breastfeed produce signals that influence the immune system development of their babies and help to prevent future food allergies, according to new global research.
Pulsed electric fields are helping fight cancer, whether by inducing tumor cell death or by stimulating the immune system.
One of the most tantalizing developments in anti-cancer therapy over recent years has been the advent of targeted treatments, which have proven highly effective in holding aggressive cancers at bay in certain patients, although typically only for a limited period of time.
Sanofi-aventis announced today the first Phase III results of the GetGoal clinical trial program assessing the efficacy and safety of lixisenatide, a once-daily GLP-1 receptor agonist, as monotherapy in patients with type 2 diabetes. These results were presented at the European Association for the Study of Diabetes (EASD) 46th Annual Meeting in Stockholm, Sweden.
Avaxia Biologics, Inc., a privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today it was awarded a contract with the Biomedical Advanced Research and Development Authority (BARDA), for the research and development of an oral antibody therapy to mitigate the gastrointestinal damage that follows radiation exposure that might occur after a nuclear incident.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Claude Lyle, MD 4301 W Markham St # 783, Little Rock, AR 72205-7101 Ph: (501) 686-8000 | Claude Lyle, MD 4301 W Markham St # 783, Little Rock, AR 72205-7101 Ph: (501) 686-8000 |
News Archive
Mothers who breastfeed produce signals that influence the immune system development of their babies and help to prevent future food allergies, according to new global research.
Pulsed electric fields are helping fight cancer, whether by inducing tumor cell death or by stimulating the immune system.
One of the most tantalizing developments in anti-cancer therapy over recent years has been the advent of targeted treatments, which have proven highly effective in holding aggressive cancers at bay in certain patients, although typically only for a limited period of time.
Sanofi-aventis announced today the first Phase III results of the GetGoal clinical trial program assessing the efficacy and safety of lixisenatide, a once-daily GLP-1 receptor agonist, as monotherapy in patients with type 2 diabetes. These results were presented at the European Association for the Study of Diabetes (EASD) 46th Annual Meeting in Stockholm, Sweden.
Avaxia Biologics, Inc., a privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today it was awarded a contract with the Biomedical Advanced Research and Development Authority (BARDA), for the research and development of an oral antibody therapy to mitigate the gastrointestinal damage that follows radiation exposure that might occur after a nuclear incident.
› Verified 7 days ago
Dr. Armando Leonel Martinez, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St, Slot 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
Sikandar Murad, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 802 N University Ave, Little Rock, AR 72205 Phone: 501-291-2322 Fax: 888-388-5166 | |
Dr. Joseph Baird Askew, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 S Shackleford Rd, Little Rock, AR 72211 Phone: 501-219-7000 | |
David Gregory Hinckley, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1701 S Shackleford Rd, Little Rock, AR 72211 Phone: 501-219-7000 | |
Matt Saenz, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4301 W Markham St # 584, Little Rock, AR 72205 Phone: 501-526-7485 | |
Dr. Timothy W Calicott, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 14623 Chambery Dr, Little Rock, AR 72211 Phone: 501-920-8556 | |
Christopher Wade Fowler, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St, Little Rock, AR 72205 Phone: 501-686-7000 |